US Patent No: 7,556,963

Number of patents in Portfolio can not be more than 2000

Feline IL-18 nucleic acid molecules

ALSO PUBLISHED AS: 20070059283

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
HESKA CORPORATIONFORT COLLINS, CO205

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wonderling, Ramani S Waukegan, IL 30 11

Cited Art Landscape

Patent Info (Count) # Cites Year
 
KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (3)
5,912,324 Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) purified from murine liver 18 1995
5,942,224 Therapeutic agent for cat respiratory diseases and method of treatment using the same 4 1995
5,914,253 Recombinant production of murine interferon--.gamma. (IFN-.gamma.) inducing factor (IGIF, IL-18) 11 1997
 
CORIXA CORPORATION (1)
6,013,268 Methods for enhancement of protective immune responses 22 1997
 
SMITHKLINE BEECHAM CORPORATION (1)
5,945,310 DNA encoding members of the IL-1 family, IL-1 delta 12 1997
 
THOMAS JEFFERSON UNIVERSITY (1)
5,858,778 SF caspase-1 and compositions for making and methods of using the same 7 1996
 
TORAY INDUSTRIES, INC. (1)
6,600,020 Canine interleukin 18 polypeptide 1 1999
 
TRUSTEES OF DARTMOUTH COLLEGE (1)
5,882,894 Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof 2 1995
 
VERTEX PHARMACEUTICALS INCORPORATED (1)
5,985,863 Compositions and methods for decreasing IGIF and IFN-.gamma. production by administering an ICE inhibitor 13 1996
 
Warner-Lambert Company (1)
5,919,790 Hydroxamate inhibitors of interleukin-1.beta. converting enzyme 23 1997

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 7, 2017
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 7, 2021
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00